SAGE-781

N/A

Report date: 2022/02/15 16:47:24
NME

Base Information

Drug NameSAGE-781
Drug Alias Name99mTc-BesilesomabSAGE-781
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsCognitive DysfunctionAlzheimer DiseaseParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSage Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSage Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionAlzheimer DiseaseParkinson Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A